相似文献
1
Biomarkers for Interstitial Lung Abnormalities: A Stepping-stone Toward Idiopathic Pulmonary Fibrosis Prevention?
Am J Respir Crit Care Med. 2022 Aug 1;206(3):244-246. doi: 10.1164/rccm.202205-0839ED.
2
Potential interstitial lung abnormalities on chest X-rays prior to symptoms of idiopathic pulmonary fibrosis.
BMC Pulm Med. 2022 Aug 30;22(1):329. doi: 10.1186/s12890-022-02122-8.
3
Interstitial lung abnormalities: erecting fences in the path towards advanced pulmonary fibrosis.
Thorax. 2019 May;74(5):506-511. doi: 10.1136/thoraxjnl-2018-212446. Epub 2019 Feb 5.
4
In search of the elusive biomarker(s): a proteomics analysis in rheumatoid arthritis-associated interstitial lung disease.
Thorax. 2022 Oct;77(10):949. doi: 10.1136/thorax-2022-219354. Epub 2022 Aug 18.
5
Subclinical Interstitial Lung Abnormalities: Toward the Early Detection of Idiopathic Pulmonary Fibrosis?
Am J Respir Crit Care Med. 2016 Dec 15;194(12):1445-1446. doi: 10.1164/rccm.201607-1363ED.
6
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2020 May 15;201(10):1240-1248. doi: 10.1164/rccm.201908-1571OC.
7
Correlation of pulmonary function and usual interstitial pneumonia computed tomography patterns in idiopathic pulmonary fibrosis.
Respir Med. 2017 Aug;129:152-157. doi: 10.1016/j.rmed.2017.06.013. Epub 2017 Jun 21.
8
Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.
Ann Am Thorac Soc. 2019 Apr;16(4):447-454. doi: 10.1513/AnnalsATS.201806-424OC.
9
Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963015. doi: 10.1177/1753466620963015.
10
Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis.
Lung. 2021 Jun;199(3):289-298. doi: 10.1007/s00408-021-00440-y. Epub 2021 Mar 26.
引用本文的文献
1
Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases.
Am J Respir Crit Care Med. 2023 Jan 1;207(1):9-11. doi: 10.1164/rccm.202209-1817ED.
本文引用的文献
1
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
2
The Proteomic Profile of Interstitial Lung Abnormalities.
Am J Respir Crit Care Med. 2022 Aug 1;206(3):337-346. doi: 10.1164/rccm.202110-2296OC.
3
CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE Cohort.
Am J Respir Crit Care Med. 2022 Jun 15;205(12):1440-1448. doi: 10.1164/rccm.202107-1769OC.
4
Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis.
Lancet Respir Med. 2022 Jun;10(6):593-602. doi: 10.1016/S2213-2600(21)00503-8. Epub 2022 Jan 18.
5
Associations of Monocyte Count and Other Immune Cell Types with Interstitial Lung Abnormalities.
Am J Respir Crit Care Med. 2022 Apr 1;205(7):795-805. doi: 10.1164/rccm.202108-1967OC.
6
Progression of traction bronchiectasis/bronchiolectasis in interstitial lung abnormalities is associated with increased all-cause mortality: Age Gene/Environment Susceptibility-Reykjavik Study.
Eur J Radiol Open. 2021 Mar 10;8:100334. doi: 10.1016/j.ejro.2021.100334. eCollection 2021.
7
The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality.
Am J Respir Crit Care Med. 2021 May 1;203(9):1149-1157. doi: 10.1164/rccm.202007-2993OC.
8
Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society.
Lancet Respir Med. 2020 Jul;8(7):726-737. doi: 10.1016/S2213-2600(20)30168-5.
9
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2020 May 15;201(10):1240-1248. doi: 10.1164/rccm.201908-1571OC.
10
Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.
Am J Respir Crit Care Med. 2020 May 15;201(10):1230-1239. doi: 10.1164/rccm.201909-1834OC.
Zotero 插件